If you're a track and field fan from the USA, chances are, you're having the time of your life right now. The post 'I Get ...

Competition in the new league, founded by American sprint great Michael Johnson, begins in April 2025. Nikki Hiltz, whose ...

Michael Johnson enjoyed 400 finals victory streak of 58 races, stretching eight years. For the first nine decades of this century, no male runner had ever won both these races in a major meet.

Michael Johnson's Grand Slam Track adds more star power to its roster after its recent signing of the three podium finishers of the 100m hurdles event of the 2024 Paris Olympics - Masai Russell ...

Michael Johnson believes his Grand Slam Track series is filling a “void” in athletics and is optimistic it will continue to attract the biggest names. The former American sprinting great hopes ...

BBC Sport's Michael Johnson says Jakob Ingebrigtsen "got his tactics wrong" during a 1500m final which saw him miss out on the medals while Team GB's Josh Kerr took silver. WATCH / READ MORE ...

If the Halloween 2023 episode of "Saturday Night Live" was the first time you heard about House Speaker Mike Johnson's "adult ...

We talk to Michael Johnson about why the world needs his new book on branding, how to improve public perceptions of what branding does and why so many designers seem to think their peers are ...

Michael Johnson is well prepared for his upcoming Grand Slam Track League, which will commence in April 2025. The former Olympic champion recently opened up on the preparations for the same in a ...

In 2049 LA, a cop known as K hunts down android labourers who have gone rogue. But when he uncovers a shocking conspiracy involving the robots, K searches for the one person who might have answers ...

An American neo-noir science-fiction film series set in a dystopian Los Angeles, depicting a future in which synthetic humans known as "replicants" are bio-engineered by the powerful Tyrell ...

By identifying the predictive biomarkers involved in Parkinson’s, we hope to speed up the eventual journey of these drugs to patients Professor Michael Johnson, lead investigator Prof Dexter ...